SCR-LIP-000379 · Claim · machine-readable JSON →
In 30 women with clinically confirmed lipedema undergoing 99mTc-nanocolloid lymphoscintigraphy, 60% showed no overt lymphatic damage while 40% showed confirmed lymphatic alterations indicating coexisting lipo-lymphedema, with lymphoscintigraphy used to detect lymphostatic components and guide surgical decisions rather than for routine lipedema diagnosis, which remains clinical.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 2 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Does lymphoscintigraphy have a role in the diagnosis and management of lipedema? — Eretta et al. (2025) ✓ verified — refining · case series · 2025 · reading confidence: high
“A linfosscintigrafia não é essencial para o diagnóstico de rotina do lipedema, que permanece clínico. Porém, é valiosa na identificação de casos com componentes linfostáticos coexistentes e na orientação de decisões cirúrgicas.”
Single-center case series evaluating lymphoscintigraphy's role in lipedema; it addresses imaging differentiation of lymphostatic involvement but concludes the test is not essential for diagnosis, refining the claim that such imaging definit
Context (PECO)
Answers these questions
- Can MRI, lymphoscintigraphy, or DXA differentiate lipedema from lymphedema and other fat distributions? refining
- Can lymphoscintigraphy differentiate lipedema from lymphedema? refining
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000023